AstraZeneca is leaving no stone unturned in its effort to make baxdrostat the first aldosterone synthase inhibitor (ASI) to get approval for hard-to-treat hypertension. The FDA has now started a ...
Like many of us, [Tim]’s seen online videos of circuit sculptures containing illuminated LED filaments. Unlike most of us, however, he went a step further by using graph theory to design glowing ...
Data center AI is driving a dramatic ramp in the growth of silicon photonics foundries: 8X growth in just 6 years, from 2026 to 2032. Scale-out is the major driver now. Scale-up will become the ...